1-dose booster, dose-escalation study assessing CV0501 in older adults
Latest Information Update: 06 Feb 2023
At a glance
- Drugs CV-0501 (Primary)
- Indications COVID 2019 infections
- Focus Adverse reactions
- 06 Feb 2023 New trial record
- 30 Jan 2023 Preliminary immunogenicity data from CV0501 in older adults published in the CureVac Media Release